EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Patient Preferences for Post‐Radical Cystectomy Treatment in Muscle‐Invasive Bladder Cancer: A Discrete Choice Experiment in Japan

Shugo Yajima, Shinro Hata, Naoya Masumori iD, Yoh Matsuoka iD, Atsuro Sawada, Jun Miki iD, Mitsuhiro Tambo iD, Yasuyuki Kobayashi, Ayumu Matsuda, Keita Nakane iD, Takashi Kobayashi iD, Hajime Tanaka iD und 6 weitere

International Journal of Urology · 2025

DOI: 10.1111/iju.70032 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Urology, 2025. Verfasst von Shugo Yajima und 17 weiteren Autor:innen. Beteiligte Einrichtung: National Cancer Center Hospital East, Chiba, Japan. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Patient Preference, Cystectomy. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bristol Myers Squibb, Ono Pharmaceutical, Bristol-Myers Squibb.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

This study aimed to assess the treatment preferences of Japanese patients with muscle‐invasive bladder cancer (MIBC) by quantifying their trade‐offs between treatment attributes using a discrete choice experiment (DCE).

Methods

A DCE was conducted among MIBC patients post‐radical cystectomy. Participants were presented with hypothetical treatment options differing in attributes such as efficacy Disease‐free survival (DFS), side effects, administration, and cost. Preference data were analyzed to determine each attribute's relative importance (RI), maximum acceptable risk (MAR), and willingness to trade efficacy (WTTE).

Results

Out of 105 patients surveyed, 101 were included in the final analysis. The DCE revealed that DFS had the highest RI (30.3%), followed by annual treatment cost (27.7%) and risk of severe side effects (26.8%). While MAR analysis indicated that patients were willing to accept some increase in side effects risk for significant gains in DFS, WTTE results showed a sensitivity to side effect severity and treatment costs, with patients often willing to trade off DFS for improvements in risks and costs. In subgroup analyses, such as pathological stage, age, and employment status, the trends for each subgroup were the same as those of the overall population. However, the magnitude of RI varied among patients with different characteristics. For example, younger patients preferred short‐term treatment duration over longer, employed patients tended to favor long‐term treatment duration.

Conclusions

This study is the first to demonstrate the treatment preferences of Japanese MIBC patients who underwent radical cystectomy, and these results can inform treatment selection based on patient preferences. Trial Registration Japan Registry of Clinical Trials: jRCT1030220680

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Urinary Bladder NeoplasmsPatient PreferenceCystectomyHumansMaleFemaleJapanAgedMiddle AgedNeoplasm InvasivenessDisease-Free SurvivalChoice BehaviorAged, 80 and overSurveys and QuestionnairesAdult

Stichwörter der Autor:innen

Japanbladder cancerdiscrete choice experimentpatient preferencepatient‐centered care

Autor:innen und Institutionen

  • National Cancer Center Hospital East, Chiba, Japan.
  • Oita University Faculty of Medicine, Oita, Japan.
  • Sapporo Medical University School of Medicine, Hokkaido, Japan.
  • Saitama Cancer Center, Saitama, Japan.
  • University of Miyazaki, Miyazaki, Japan.
  • The Jikei University Kashiwa Hospital, Chiba, Japan.

ORCID-Profile: Naoya Masumori, Yoh Matsuoka, Jun Miki, Mitsuhiro Tambo, Keita Nakane, Takashi Kobayashi, Hajime Tanaka, Eiji Kikuchi

Förderung

  • Bristol Myers Squibb
  • Ono Pharmaceutical
  • Bristol-Myers Squibb

Zitieren

APA

Yajima, S., Hata, S., Masumori, N., Matsuoka, Y., Sawada, A., Miki, J., Tambo, M., Kobayashi, Y., Matsuda, A., Nakane, K., Kobayashi, T., Tanaka, H., Yamaguchi, N., Kaneko, G., Miller, R., Seto, T., Ito, H., & Kikuchi, E. (2025). Patient Preferences for Post‐Radical Cystectomy Treatment in Muscle‐Invasive Bladder Cancer: A Discrete Choice Experiment in Japan. International Journal of Urology. https://doi.org/10.1111/iju.70032

Vancouver

Yajima S, Hata S, Masumori N, Matsuoka Y, Sawada A, Miki J, et al. Patient Preferences for Post‐Radical Cystectomy Treatment in Muscle‐Invasive Bladder Cancer: A Discrete Choice Experiment in Japan. International Journal of Urology. 2025. doi:10.1111/iju.70032

BibTeX
@article{Yajima2025,
  author = {Yajima, Shugo and Hata, Shinro and Masumori, Naoya and Matsuoka, Yoh and Sawada, Atsuro and Miki, Jun and Tambo, Mitsuhiro and Kobayashi, Yasuyuki and Matsuda, Ayumu and Nakane, Keita and Kobayashi, Takashi and Tanaka, Hajime and Yamaguchi, Noriya and Kaneko, Go and Miller, Russell and Seto, Takehiro and Ito, Hiroaki and Kikuchi, Eiji},
  title = {Patient Preferences for Post‐Radical Cystectomy Treatment in Muscle‐Invasive Bladder Cancer: A Discrete Choice Experiment in Japan},
  journal = {International Journal of Urology},
  year = {2025},
  doi = {10.1111/iju.70032}
}
Kostenlos starten →